Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?-Reference-Cited by-同舟云学术

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?

Published:2023-09-18 Issue:18 Volume:15 Page:4621
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Stenman Adam¹²^ORCID,Juhlin Carl Christofer³⁴^ORCID

Affiliation:

1. Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Sweden

2. Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital Solna, 17176 Stockholm, Sweden

3. Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden

4. Department of Pathology and Cancer Diagnostics, Karolinska University Hospital Solna, 17176 Stockholm, Sweden

Abstract

Anaplastic thyroid carcinoma (ATC) stands as a rare but extraordinarily lethal tumor, marked by its limited treatment options [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/18/4621/pdf

Reference12 articles.

1. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000–2019;Maniakas;JAMA Oncol.,2020

2. Aberrant DNA Repair as a Potential Contributor for the Clonal Evolution in Subsets of Anaplastic Thyroid Carcinomas Arising through Dedifferentiation: Implications for Future Therapeutic Algorithms?;Juhlin;Cancer Drug Resist.,2020

3. Characterization of the Mutational Landscape of Anaplastic Thyroid Cancer via Whole-Exome Sequencing;Kunstman;Hum. Mol. Genet.,2015

4. Anaplastic Thyroid Carcinoma: Advances in Molecular Profiling and Targeted Therapy;Jungels;Curr. Opin. Oncol.,2023

5. BRAF V600E Inhibition in Anaplastic Thyroid Cancer;Rosove;N. Engl. J. Med.,2013